Related Experiment Video
Updated: Jun 2, 2026
09:45
Isolation and Profiling of Human Primary Mesenteric Arterial Endothelial Cells at the Transcriptome Level
Published on: March 14, 2022
Gene Expression Profiles at Early vs Late Stages After Cervical Artery Dissection
Robert B Ferguson1, Ilana E Green2, Timothy L Mcmurry3
1Department of Neurology, University of Virginia, Charlottesville.
Neurology. Genetics
|June 1, 2026
Summary
Early cervical artery dissection (CeAD) shows a unique gene expression profile, distinct from later stages and healthy individuals. Hemoglobin metabolism genes were notably altered, suggesting a new research direction for arterial dissection.
Area of Science:
- Genomics
- Vascular Biology
- Stroke Research
Background:
- Cervical artery dissection (CeAD) is a leading cause of stroke in young adults.
- Its underlying pathogenesis is poorly understood, but suggests a systemic arteriopathy.
- Genetic factors may play a role in early CeAD development.
Purpose of the Study:
- To identify a distinct gene expression profile in early-phase CeAD.
- To compare early CeAD gene expression with late-phase CeAD and healthy controls.
- To investigate potential molecular mechanisms underlying CeAD.
Main Methods:
- Prospective enrollment of 37 CeAD patients and controls (16 non-CeAD stroke, 11 healthy).
- Blood samples collected within 4 weeks and at 3-6 months follow-up.
- Microarray analysis assessed gene expression, analyzed using mixed-effects regression with FDR < 5% and fold change > 1.5.
Main Results:
- 1,238 genes were differentially expressed in early CeAD vs. late-phase (31 genes > 1.5-fold change).
- 538 genes differed between early CeAD and controls (30 genes > 1.5-fold change).
- 7 of 11 differentially expressed genes in late CeAD vs. controls were linked to hemoglobin metabolism.
Conclusions:
- A distinct gene expression signature characterizes early-phase CeAD.
- Hemoglobin metabolism alterations warrant further investigation in arterial dissection.
- This preliminary study highlights potential molecular pathways in CeAD pathogenesis.
